Welcome to LookChem.com Sign In|Join Free

CAS

  • or
L-GLUTAMIC ACID, BIS PHENYLMETHYL ESTER, 4-METHYL BENZENESULFONATE HOMOPOLYMER is a complex chemical entity that combines the properties of an essential amino acid, a synthetic ester, and a homopolymer. L-Glutamic acid is vital for protein synthesis and neurotransmission in the brain. Bis phenylmethyl ester, formed by linking two phenylmethyl esters, is utilized in plastic manufacturing. The 4-methyl benzenesulfonate homopolymer, derived from 4-methyl benzenesulfonate, is widely used in adhesives and coatings. This unique combination of components endows the compound with diverse industrial applications, from neurological enhancement to material property improvement.

227205-81-4 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 227205-81-4 Structure
  • Basic information

    1. Product Name: L-GLUTAMIC ACID, BIS PHENYLMETHYL ESTER, 4-METHYL BENZENESULFONATE HOMOPOLYMER
    2. Synonyms: L-GLUTAMIC ACID, BIS PHENYLMETHYL ESTER, 4-METHYL BENZENESULFONATE HOMOPOLYMER
    3. CAS NO:227205-81-4
    4. Molecular Formula: C26H29NO7S
    5. Molecular Weight: 499.57596
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 227205-81-4.mol
  • Chemical Properties

    1. Melting Point: N/A
    2. Boiling Point: 453.5°Cat760mmHg
    3. Flash Point: 165.6°C
    4. Appearance: /
    5. Density: g/cm3
    6. Refractive Index: N/A
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: L-GLUTAMIC ACID, BIS PHENYLMETHYL ESTER, 4-METHYL BENZENESULFONATE HOMOPOLYMER(CAS DataBase Reference)
    10. NIST Chemistry Reference: L-GLUTAMIC ACID, BIS PHENYLMETHYL ESTER, 4-METHYL BENZENESULFONATE HOMOPOLYMER(227205-81-4)
    11. EPA Substance Registry System: L-GLUTAMIC ACID, BIS PHENYLMETHYL ESTER, 4-METHYL BENZENESULFONATE HOMOPOLYMER(227205-81-4)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. WGK Germany:
    5. RTECS:
    6. HazardClass: N/A
    7. PackingGroup: N/A
    8. Hazardous Substances Data: 227205-81-4(Hazardous Substances Data)

227205-81-4 Usage

Uses

Used in Pharmaceutical Industry:
L-GLUTAMIC ACID, BIS PHENYLMETHYL ESTER, 4-METHYL BENZENESULFONATE HOMOPOLYMER is used as a pharmaceutical agent for enhancing neurological function due to its role in protein synthesis and neurotransmission.
Used in Plastics Manufacturing:
In the plastics industry, L-GLUTAMIC ACID, BIS PHENYLMETHYL ESTER, 4-METHYL BENZENESULFONATE HOMOPOLYMER is used as a component in the production of various types of plastics, leveraging the properties of bis phenylmethyl ester to improve the physical characteristics of the final products.
Used in Adhesives and Coatings Production:
L-GLUTAMIC ACID, BIS PHENYLMETHYL ESTER, 4-METHYL BENZENESULFONATE HOMOPOLYMER is used as a key ingredient in the formulation of adhesives and coatings, where the 4-methyl benzenesulfonate homopolymer contributes to the adhesive and coating properties, such as bonding strength and durability.
These applications highlight the versatility of L-GLUTAMIC ACID, BIS PHENYLMETHYL ESTER, 4-METHYL BENZENESULFONATE HOMOPOLYMER across different industries, showcasing its potential in both health-related and material science applications.

Check Digit Verification of cas no

The CAS Registry Mumber 227205-81-4 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,2,7,2,0 and 5 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 227205-81:
(8*2)+(7*2)+(6*7)+(5*2)+(4*0)+(3*5)+(2*8)+(1*1)=114
114 % 10 = 4
So 227205-81-4 is a valid CAS Registry Number.

227205-81-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name dibenzyl 2-aminopentanedioate,4-methylbenzenesulfonic acid

1.2 Other means of identification

Product number -
Other names L-GLUTAMIC ACID DIBENZYL ESTER-P-TOSYLATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:227205-81-4 SDS

227205-81-4Relevant articles and documents

p-Toluenesulfonyl Chloride Catalysed Facile Synthesis of O-benzyl-l-amino Acids and Their In Vitro Evaluation

Hegde, Namita,Juvale, Kapil,Prabhakar, Bala

, p. 2129 - 2135 (2020/01/11)

Protection and subsequent deprotection of amino acid functional groups play a key role in regioselective peptide synthesis. For protection, carboxylic acid functional groups are often benzylated using p-toluenesulfonic acid catalysed Fischer-Speier esterification reaction. Such reaction involves in situ water formation, which requires subsequent separation by azeotropic distillation for forward shift of equilibrium. To eliminate the need of this corresponding step requiring additional set-up, current study investigated p-toluenesulfonyl chloride as a reasonable alternative catalyst for facile benzylation of selected mono- and di- carboxylic amino acids. Literature reports that p-toluenesulfonyl chloride not only has a better shelf life but also demonstrates better safety in case of accidental systemic absorption over p-toluenesulfonic acid. As the O-benzyl-l-amino acids are often retained without deprotection to constitute the pharmaceutical peptide systems, synthesized compounds were investigated for their biocompatibility using in vitro cytotoxicity assays.

Synthesis and structure reassignment of malylglutamate, a recently discovered earthworm metabolite

Griffith, Corey M.,Feceu, Abigail,Larive, Cynthia K.,Martin, David B. C.

, p. 417 - 421 (2019/02/19)

Malylglutamate, a newly identified metabolite in earthworms, was synthesized using a traditional peptide coupling approach for assembling the amide from protected malate and glutamate precursors. The proposed structure (1) and a diastereomer were synthesized, but their NMR spectra did not match the natural sample. Further analysis of the natural sample using HMBC spectroscopy suggested an alternative attachment of the malyl moiety, and β-malylglutamate (2) diastereomers were synthesized, L,L-2 and D,D-2. NMR spectra were an excellent match with the natural sample, and chiral-phase chromatography was employed to identify (a)-β-l-malyl-l-glutamate (2) as the isomer native to Eisenia fetida.

CONJUGATES OF WATER SOLUBLE POLYMER-AMINO ACID OLIGOPEPTIDE-DRUG, PREPARATION METHOD AND USE THEREOF

-

Paragraph 0134; 0135, (2015/12/31)

A conjugate of water soluble polymer-amino acid oligopeptide-drug of Formula (I) below and a pharmaceutical composition comprising the conjugate are provided. In the conjugate, P is a water soluble polymer; X is a linking group, wherein the linking group links P and A1; each of A1, A2 and A3 is independently same or different amino acid residue or amino acid analogue residue; each of D1 and D2 is independently same or different drug molecule residue; a is 0 or 1; b is an integer of 2-12; c is an integer of 0-7; d is 0 or 1. The conjugate could improve drug load capacity, water solubility, stability and activity of the drug.

The discovery of a facile access to the synthesis of NSAID dendritic prodrugs

Du, Zuyin,Lu, Yanhui,Dai, Xuedong,Negrerie, Daisy Zhang,Gao, Qingzhi

, p. 177 - 180 (2013/07/05)

An efficient and straightforward method for the preparation of dendritic prodrugs is reported. Based on this new approach, a class of biodegradable dendrimers has been synthesised from L-tartaric acid and one of the nonsteroidal anti-inflammatory drugs, namely, aspirin or ibuprofen Tianjin Key Laboratory for Modern Drug Delivery and High-Efficiency, School of Pharmaceutical Science and Technology, Tianjin Universit ,Tianjin 300072, P. R. China.

Synthesis of NO-NSAID dendritic prodrugs via Passerini reaction:new approach to the design of dendrimer-drug conjugates

Du, Zuyin,Yanhui, Lu,Dai, Xuedong,Zhang-Negrerie, Daisy,Gao, Qingzhi

, p. 181 - 185 (2013/07/05)

We report the synthesis of a novel class of dendritic prodrugs via Passerini reaction in one pot. Such dendrimers feature a simultaneous attachment of a conventional non-steroidal anti-inflammatory drug (NSAID) (such as ibuprofen and aspirin) and a nitric oxide (NO)-releasing moiety (such as an organic nitrate) onto their surface, and are therefore regarded as new drug delivery systems for NO-releasing NSAIDs (NO-NSAIDs).

Inhibitors for bacterial cell-wall recycling

Yamaguchi, Takao,Blazquez, Blas,Hesek, Dusan,Lee, Mijoon,Llarrull, Leticia I.,Boggess, Bill,Oliver, Allen G.,Fisher, Jed F.,Mobashery, Shahriar

supporting information; experimental part, p. 238 - 242 (2012/05/04)

Gram-negative bacteria have evolved an elaborate process for the recycling of their cell wall, which is initiated in the periplasmic space by the action of lytic transglycosylases. The product of this reaction, β-d-N- acetylglucosamine-(1a?'4)-1,6-anhydro-β-d-N-acetylmuramyl-l- Ala-I-d-Glu-meso-DAP-d-Ala-d-Ala (compound 1), is internalized to begin the recycling events within the cytoplasm. The first step in the cytoplasmic recycling is catalyzed by the NagZ glycosylase, which cleaves in a hydrolytic reaction the N-acetylglucosamine glycosidic bond of metabolite 1. The reactions catalyzed by both the lytic glycosylases and NagZ are believed to involve oxocarbenium transition species. We describe herein the synthesis and evaluation of four iminosaccharides as possible mimetics of the oxocarbenium species, and we disclose one as a potent (compound 3, Ki = 300 A± 15 nM) competitive inhibitor of NagZ.

Tryptophan-containing dipeptide derivatives as potent PPARγ antagonists: Design, synthesis, biological evaluation, and molecular modeling

Deng, Guanghui,Liu, Zhiguo,Ye, Fei,Luo, Xiaomin,Zhu, Weiliang,Shen, Xu,Liu, Hong,Jiang, Hualiang

experimental part, p. 2699 - 2716 (2009/04/11)

The discovery of peroxisome proliferator-activated receptor γ (PPARγ) antagonists (also termed "selective PPARγ modulators, SPPARγM") is now of a great interest in the treatment of diabetes and obesity. The structure of compound 1a (G3335, Fig. 1), a novel class of PPARγ antagonist, is entirely different from that of other reported PPARγ antagonists. A series of 35 novel analogues (1b-l, 9a-d, 13a-t) were designed, synthesized and evaluated against the agonistic effects exerted by rosiglitazone. These results indicated that most functional groups of 1a were conserved, and six new compounds (1b, 1c, and 9a-d) exhibited strong PPARγ antagonistic activities (IC50 values of 5.2-25.8 μM) against 10 μM rosiglitazone in the promotion of the PPARγ-LBD-CBP (ligand-binding domain and cAMP-response-element binding protein) interaction as investigated by yeast two-hybrid technology based assay. Molecular modeling studies for compounds 1a-d, 1h, 9c-d, and 13a were also presented.

The synthesis of pyrimidin-4-yI substituted a-amino acids. a versatile approach from alkynyl ketones

Adlington, Robert M.,Baldwin, Jack E.,Catterick, David,Pritchard, Garcth J.

, p. 855 - 866 (2007/10/03)

The reaction of amidines with a-amino acid alkynyl ketones is shown to be a versatile route to pyrimidin-4-yl substituted a-amino acids. This route is also applicable to a parallel synthesis approach and has allowed the formation of a range of pyrimidin-4-yl substituted a-amino acids, including the naturally occurring a-amino acid L-lathyrine 4.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 227205-81-4